Stephen Christopher Linthwaite Standard Biotools Inc. (LAB) insider trading activity

Stephen Christopher Linthwaite is President & CEO of STANDARD BIOTOOLS INC.. Currently has a direct ownership of 328,473 shares of LAB, which is worth approximately $518,987. The most recent transaction as insider was on Feb 22, 2022, when has been sold 12,465 shares (Common Stock) at a price of $3.62 per share, resulting in proceeds of $45,123. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 328K

0% 3M change

0% 12M change

Total Value Held $518,987

Stephen Christopher Linthwaite Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 22 2022	SELL Payment of exercise price or tax liability	$45,123 $3.62 p/Share	12,465 Reduced 3.66%	328,473 Common Stock
Feb 22 2022	BUY Exercise of conversion of derivative security	-	22,417 Added 6.17%	340,938 Common Stock
Nov 20 2021	SELL Payment of exercise price or tax liability	$50,679 $4.49 p/Share	11,287 Reduced 3.46%	315,224 Common Stock
Nov 20 2021	BUY Exercise of conversion of derivative security	-	22,417 Added 6.42%	326,511 Common Stock
Aug 20 2021	SELL Payment of exercise price or tax liability	$73,704 $6.53 p/Share	11,287 Reduced 3.58%	304,094 Common Stock
Aug 20 2021	BUY Exercise of conversion of derivative security	-	22,417 Added 6.64%	315,381 Common Stock
May 20 2021	SELL Payment of exercise price or tax liability	$493,096 $5.52 p/Share	89,329 Reduced 23.48%	291,169 Common Stock
May 20 2021	BUY Exercise of conversion of derivative security	-	177,417 Added 31.8%	380,498 Common Stock
Feb 20 2021	SELL Payment of exercise price or tax liability	$353,155 $6.12 p/Share	57,705 Reduced 22.13%	203,081 Common Stock
Feb 20 2021	BUY Grant, award, or other acquisition	-	64,609 Added 19.86%	260,786 Common Stock
Feb 20 2021	BUY Exercise of conversion of derivative security	-	48,750 Added 19.9%	196,177 Common Stock
Nov 23 2020	SELL Open market or private sale	$514,009 $6.06 p/Share	84,820 Reduced 36.85%	145,347 Common Stock
Nov 20 2020	SELL Payment of exercise price or tax liability	$61,487 $6.28 p/Share	9,791 Reduced 4.08%	230,167 Common Stock
Nov 20 2020	BUY Exercise of conversion of derivative security	-	19,445 Added 7.5%	239,958 Common Stock

SCL

Stephen Christopher Linthwaite

President & CEO

South San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LAB shares.

Notify only if

Value

Insider Trading

Get notified when an Standard Biotools Inc. insider buys or sells LAB shares.

Notify only if

Operation

Value

Type

News

Receive news related to STANDARD BIOTOOLS INC.

Track Activities on LAB

Account